197A — TAUNS Laboratories Cashflow Statement
0.000.00%
- ¥51bn
- ¥50bn
- ¥16bn
- 26
- 42
- 50
- 30
Annual cashflow statement for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | JAS | JAS |
Status: | Final | Final |
Net Income/Starting Line | 7,976 | 4,655 |
Depreciation | ||
Non-Cash Items | 3,363 | 327 |
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | 773 | -8,779 |
Change in Accounts Receivable | ||
Change in Inventories | ||
Change in Accounts Payable | ||
Change in Taxes Payable | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | 12,679 | -3,158 |
Capital Expenditures | -2,300 | -1,166 |
Purchase of Fixed Assets | ||
Purchase / Acquisition of Intangibles | ||
Other Investing Cash Flow Items | -380 | -450 |
Sale of Fixed Assets | ||
Purchase of Investments | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | -2,680 | -1,615 |
Financing Cash Flow Items | -1,800 | -1,900 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | -3,660 | -330 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 6,339 | -5,103 |